Panax (ginseng) - Panacea or placebo? Molecular and cellular basis of its pharmacological activity

Annals of the Academy of Medicine Singapore

Volumn 29, Issue 1, 2000, Pages 42-46

  Ong, Y C ^b   Yong, E L ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NONE

Author keywords

Adaptogen; Ginsenosides; Scientific evidence; Tonic

Indexed keywords

ANTIDIABETIC AGENT; ANTIINFLAMMATORY AGENT; ANTIMUTAGENIC AGENT; ANTINEOPLASTIC AGENT; GINSENG EXTRACT;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; DRUG ACTIVITY; DRUG EFFECT; DRUG RESEARCH; HERBAL MEDICINE; HUMAN; MEDICAL LITERATURE; NONHUMAN;

EID: 0034118871     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Medon P J, Ferguson P W, Watson C F. Effects of Eleutherococcus senticosus extracts on hexobarbital metabolism in vivo and in vitro. J Ethnopharmacol 1984; 10:235-41.
2. Chubarev V N, Rubtsova E R, Filatova I V, Krendal F P, Davydova O N. Immunotropic effect of a tincture of the tissue culture biomass of ginseng cells and of an Eleutherococcus extract in mice. Farmakol Toksikol 1989; 52:55-9.
3. Duke J A. Ginseng: a concise handbook. Michigan: Reference Publications, 1989.
4. Petkov W. Pharmaceutical studies of the drug, Panax ginseng C. A. Meyer I. Arzneim-Forsch 1959; 9:305.
5. Brekhman II, Dardymov IV, Dobriakov IuI. On the pharmacology of individual glycosides from the roots of Panax ginseng C.A. Meyer. Farmakol Toksikol 1966; 29:167-71.
6. Hostettmann K, Marston A, Saponins. Cambridge, New York: Cambridge Univ Press, 1995.
7. Nagai Y, Tanaka O, Shibata S. Chemical studies on the oriental plant drugs XXIV: structure of ginsenoside Rg-1 a new saponin of Ginseng root. Tetrahedron 1971; 27:881.
8. Sanada S, Kondo N, Shoji J, Tanaka O, Shibata S. Studies on the saponins of Ginseng II: structures of ginsenoside Re, Rf and Rg-2. Chem Pharm Bull (Tokyo) 1974; 22:2407.
9. Kim Y H, Park K H, Rho H M. Transcriptional activation of the Cu,Zn-superoxide dismutase gene through the AP2 site by ginsenoside Rb2 extracted from a medicinal plant, Panax ginseng. J Biol Chem 1996;271:24539-43.
10. Huang T T, Carlson E J, Leadon S A, Epstein C J. Relationship of resistance to oxygen free radicals to CuZn-superoxide dismutase activity in transgenic, transfected, and trisomic cells. FASEB J 1992; 6: 903-10.
11. Fridovich I. Superoxide dismutases. Annu Rev Biochem 1975; 44:147-59.
12. Watanabe Y, Kuno N, Kono Y, Nanba E, Ohama E, Nakashima K, et al. Absence of the mutant SOD1 in familial amyotrophic lateral sclerosis (FALS) with two base pair deletion in the SOD1 gene. Acta Neurol Scand 1997; 95:167-72.
13. McFadden S L, Ding D, Reaume A G, Flood D G, Salvi R J. Age-related cochlear hair cell loss is enhanced in mice lacking copper/zinc superoxide dismutase. Neurobiol Aging 1999; 20:1-8.
14. Cardozo-Pelaez F, Song S, Parthasarathy A, Epstein C J, Sanchez-Ramos J. Attenuation of age-dependent oxidative damage to DNA and protein in brainstem of Tg Cu/Zn SOD mice. Neurobiol Aging 1998; 19:311-6.
15. McCord J M, Keele B B Jr, Fridovich I. An enzyme-based theory of obligate anaerobiosis: the physiological function of superoxide dismutase. Proc Natl Acad Sci U S A 1971; 68:1024-7.
16. Zhu J H, Takeshita T, Kitagawa I, Morimoto K. Suppression of the formation of sister chromatid exchanges by low concentrations of ginsenoside Rh2 in human blood lymphocytes. Cancer Res 1995; 55:1221-3.
17. Nishi Y, Hasegawa M M, Taketomi M, Ohkawa Y, Inui N. Comparison of 6-thioguanine-resistant mutation and sister chromatid exchanges in Chinese hamster V79 cells with forty chemical and physical agents. Cancer Res 1984; 44:3270-9.
18. Lee K Y, Park J A, Chung E, Lee Y H, Kim S I, Lee S K. Ginsenoside-Rh2 blocks the cell cycle of SK-HEP-1 cells at the G1/S boundary by selectively inducing the protein expression of p27kip1. Cancer Lett 1996; 110:193-200.
19. Byun B H, Shin I, Yoon Y S, Kim S I, Joe C O. Modulation of protein kinase C activity in NIH 3T3 cells by plant glycosides from Panax ginseng. Planta Med 1997; 63:389-92.
20. Blackshear P J, Stumpo D J, Huang J K, Nemenoff R A, Spach D H. Protein kinase C-dependent and -independent pathways of proto-oncogene induction in human astrocytoma cells. J Biol Chem 1987; 262:7774-81.
21. Kaplan D R, Whitman M, Schaffhausen B, Raptis L, Garcea R L, Pallas D, et al. Phosphatidylinositol metabolism and polyoma-mediated transformation. Proc Natl Acad Sci USA 1986; 83:3624-8.
22. Staddon J M, Chanter N, Lax A J, Higgins T E, Rozengurt E. Pasteurella multocida toxin, a potent mitogen, stimulates protein kinase C-dependent and -independent protein phosphorylation in Swiss 3T3 cells. J Biol Chem 1990; 265:11841-8.
23. Oh M, Choi Y H, Choi S, Chung H, Kim K, Kim S I, et al. Antiproliferating effects of ginsenoside Rh2 on MCF-7 human breast cancer cells. Int J Oncol 1999; 14:869-75.
24. Strickland S, Smith K K, Marotti K R. Hormonal induction of differentiation in teratocarcinoma stem cells: generation of parietal endoderm by retinoic acid and dibutyryl cAMP. Cell 1980; 21:347-55.
25. Lee Y N, Lee H Y, Chung H Y, Kim S I, Lee S K, Park B C, et al. In vitro induction of differentiation by ginsenoides in F9 teratocarcinoma cells. Eur J Cancer 1996; 32A: 1420-8.
26. Lee Y N, Lee H Y, Lee Y M, Chung H Y, Kim S I, Lee S K, et al. Involvement of glucocorticoid receptor in the induction of differentiation by ginsenosides in F9 teratocarcinoma cells. J Steroid Biochem Mol Biol 1998; 67:105-11.
27. Park J A, Lee K Y, Oh Y J, Kim K W, Lee S K. Activation of caspase-3 protease via a Bcl-2-insensitive pathway during the process of ginsenoside Rh2-induced apoptosis. Cancer Lett 1997; 121:73-81.
28. Park J A, Kim K W, Kim S I, Lee S K. Caspase 3 specifically cleaves p21WAF1/CIP1 in the earlier stage of apoptosis in SK-HEP-1 human hepatoma cells. Eur J Biochem 1998; 257:242-8.
29. Rao L, White E. Bcl-2 and the ICE family of apoptotic regulators: making a connection. Curr Opin Genet Dev 1997; 7:52-8.
30. Lazebnik Y A, Kaufmann S H, Desnoyers S, Poirier G G, Earnshaw W C. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 1994; 371:346-7.
31. Tewari M, Quan L T, O'Rourke K, Desnoyers S, Zeng Z, Beidler D R, et al. Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 1995; 81:801-9.
32. Kim S E, Lee Y H, Park J H, Lee S K. Ginsenoside-Rs3, a new diol-type ginseng saponin, selectively elevates protein levels of p53 and p21WAF1 leading to induction of apoptosis in SK-HEP-1 cells. Anticancer Res 1999; 19:487-91.
33. Kim S E, Lee Y H, Park J H, Lee S K. Ginsenoside-Rs4, a new type of ginseng saponin concurrently induces apoptosis and selectively elevates protein levels of p53 and p21WAF1 in human hepatoma SK-HEP-1 cells. Eur J Cancer 1999; 35:507-11.
34. Hasegawa H, Sung J H, Matsumiya S, Uchiyama M, Inouye Y, Kasai R, et al. Reversal of daunomycin and vinblastine resistance in multidrug-resistant P388 leukemia in vitro through enhanced cytotoxicity by triterpenoids. Planta Med 1995; 61:409-13.
35. Matsuda H, Samukawa K, Kubo M. Anti-hepatitic activity of ginsenoside Ro. Planta Med 1991; 57:523-6.
36. Matsuda H, Samukawa K, Kubo M. Anti-inflammatory activity of ginsenoside Ro. Planta Med 1990; 56:19-23.
37. Yokozawa T, Yasui T, Oura H. Molecular biological analysis of the effects of ginsenoside-Rb2 on albumin mRNA in streptozotocin-induced diabetic rats. J Pharm Pharmacol 1996; 48:763-7.
38. Yokozawa T, Oura H. Facilitation of protein biosynthesis by ginsenoside-Rb2 administration in diabetic rats. J Nat Prod 1990; 53:1514-8.
39. Yokozawa T, Fujitsuka N, Yasui T, Oura H. Effects of ginsenoside-Rb2 on adenine nucleotide content of rat hepatic tissue. J Pharm Pharmacol 1991; 43:290-1.
40. Bondy PK. Diabetes mellitus. In: Beeson PB, McDermott W. editors. Textbook of Medicine. Philadelphia: W B Saunders Co, 1971:1639-56.
41. Kim N D, Kang S Y. Park J H. Schini-Kerth V B. Ginsenoside Rg3 mediates endothelium-dependent relaxation in response to ginsenosides in rat aorta: role of K+ channels. Eur J Pharmacol 1999; 367:41-9.
42. Kim N D, Kang S Y, Kim M J, Park J H, Schini-Kerth V B. The ginsenoside Rg3 evokes endothelium-independent relaxation in rat aortic rings: role of K+ channels. Eur J Pharmacol 1999; 367:51-7.
43. Jayakody R L, Kappagoda C T, Senaratne M P, Sreeharan N. Absence of effect of calcium antagonists on endothelium-dependent relaxation in rabbit aorta. Br J Pharmacol 1987; 91:155-64.
44. Lawson K. Potassium channel activation: a potential therapeutic approach? Pharmacol Ther 1996; 70:39-63.
45. Edwards G, Weston A H. Pharmacology of the potassium channel openers. Cardiovasc Drugs Ther 1995; 9 (Suppl 2): 185-93.
46. Tachikawa E, Kudo K, Kashimoto T, Takahashi E. Ginseng saponins reduce acetylcholine-evoked Na+ influx and catecholamine secretion in bovine adrenal chromaffin cells. J Pharmacol Exp Ther 1995; 273:629-36.
47. Tachikawa E, Kudo K, Harada K, Kashimoto T, Miyate Y, Kakizaki A, et al. Effects of ginseng saponins on responses induced by various receptor stimuli. Eur J Pharmacol 1999; 369:23-32.
48. Tsang D, Ho K W, Tse T K, Tsang P C, Wen H E. Ginsenoside modulates K+-stimulated noradrenaline release from rat cerebral cortex slices. Planta Med 1986; 4:266-8.
49. Yun T K, Choi S Y. Preventive effect of ginseng intake against various human cancers: a case-control study on 1987 pairs. Cancer Epidemiol Biomarkers Prev 1995; 4:401-8.
50. Yun T K, Choi S Y. Non-organ specific cancer prevention of ginseng: a prospective study in Korea. Int J Epidemiol 1998; 27:359-64.
51. Ahn Y O. Diet and stomach cancer in Korea. Int J Cancer 1997; (Suppl 10):7-9.
52. Zuin M, Battezzati P M, Camisasca M, Riebenfeld D, Podda M. Effects of a preparation containing a standardized ginseng extract combined with trace elements and multivitamins against hepatotoxin-induced chronic liver disease in the elderly. J Int Med Res 1987; 15:276-81.
53. Sotaniemi E A, Haapakoski E, Rautio A. Ginseng therapy in non-insulin-dependent diabetic patients. Diabetes Care 1995; 18:1373-5.
54. Scaglione F, Cattaneo G, Alessandria M, Cogo R. Efficacy and safety of the standardised Ginseng extract G1 15 for potentiating vaccination against the influenza syndrome and protection against the common cold. Drugs Exp Clin Res 1996; 22:65-72.
55. Caso Marasco A, Vargas Ruiz R, Salas Villagomez A, Begona Infante C. Double-blind study of a multivitamin complex supplemented with ginseng extract. Drugs Exp Clin Res 1996; 22:323-9.